BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1924851)

  • 1. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.
    Maciejewski B; Majewski S
    Radiother Oncol; 1991 Jul; 21(3):163-70. PubMed ID: 1924851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
    Withers HR; Taylor JM; Maciejewski B
    Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
    Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice.
    Hessel F; Petersen C; Zips D; Krause M; Pfitzmann D; Thames HD; Baumann M
    Int J Radiat Biol; 2003 Jul; 79(7):479-86. PubMed ID: 14530155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy.
    Slevin NJ; Hendry JH; Roberts SA; Agren-Cronqvist A
    Radiother Oncol; 1992 Aug; 24(4):215-20. PubMed ID: 1410576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.
    Marks LB; Dewhirst M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1377-83. PubMed ID: 1938539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The radiation therapy of bladder cancer in a regimen of nontraditional fractionation with local radiomodification by metronidazole].
    Pereslegin IA; Mufazalov FF
    Med Radiol (Mosk); 1991; 36(12):26-8. PubMed ID: 1749327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
    Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours.
    Dubben HH
    Radiother Oncol; 1994 Sep; 32(3):197-200. PubMed ID: 7816938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
    Milas L; Nakayama T; Hunter N; Jones S; Lin TM; Yamada S; Thames H; Peters L
    Radiother Oncol; 1994 Mar; 30(3):247-53. PubMed ID: 8209009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer.
    Plataniotis G; Michalopoulos E; Kouvaris J; Vlahos L; Papavasiliou C
    Radiother Oncol; 1994 Oct; 33(1):84-7. PubMed ID: 7878215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic fractionation of the radiation dosage combined with the local use of metronidazole in bladder cancer].
    Pereslegin IA; Vinogradskiĭ AG; Mufazalov FF
    Med Radiol (Mosk); 1989 Dec; 34(12):45-9. PubMed ID: 2601593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of tumor size and repopulation for radiocurability of skin cancer.
    Maciejewski BA; Skates S; Zajusz A; Lange D
    Neoplasma; 1993; 40(1):51-4. PubMed ID: 8350948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reduction of tumour control with increasing overall time: mathematical considerations.
    Jones B; Dale RG
    Br J Radiol; 1996 Sep; 69(825):830-8. PubMed ID: 8983587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
    Begg AC; Hofland I; Kummermehr J
    Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
    Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.